Published in Minerva Dermatol on January 01, 1966
Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst (1992) 8.69
Regulation of longevity and stress resistance by Sch9 in yeast. Science (2001) 5.93
Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma. J Clin Oncol (1994) 3.48
Linear accelerator radiosurgery of cerebral arteriovenous malformations: an update. Neurosurgery (1994) 1.78
Intratumoral microvessel density and p53 protein: correlation with metastasis in head-and-neck squamous-cell carcinoma. Int J Cancer (1993) 1.44
Dosimetric considerations on multiple arc stereotaxic radiotherapy. Radiother Oncol (1988) 1.39
Evaluating the potential usefulness of new prognostic and predictive indicators in node-negative breast cancer patients. J Natl Cancer Inst (1993) 1.37
Human breast cancer: prognostic significance of the c-erbB-2 oncoprotein compared with epidermal growth factor receptor, DNA ploidy, and conventional pathologic features. J Clin Oncol (1992) 1.14
External stereotactic irradiation by linear accelerator. Neurosurgery (1985) 1.10
New technique for three-dimensional linear accelerator radiosurgery. Acta Neurochir Suppl (Wien) (1987) 1.03
c-erbB-3 and c-erbB-2 protein expression in node-negative breast carcinoma--an immunocytochemical study. Eur J Cancer (1994) 1.01
Preferential delivery of liposome-incorporated porphyrins to neoplastic cells in tumour-bearing rats. Br J Cancer (1983) 0.99
Value of epidermal growth factor receptor status compared with growth fraction and other factors for prognosis in early breast cancer. Br J Cancer (1992) 0.92
Elimination pathway of hematoporphyrin from normal and tumor-bearing rats. Tumori (1982) 0.91
Linear accelerator radiosurgery of cerebral arteriovenous malformations. Neurosurgery (1989) 0.87
Weekly epirubicin versus doxorubicin as second line therapy in advanced breast cancer. A randomized clinical trial. Am J Clin Oncol (1991) 0.86
Breast cancer cell kinetics: immunocytochemical determination of growth fractions by monoclonal antibody Ki-67 and correlation with flow cytometric S-phase and with some features of tumor aggressiveness. Anticancer Res (1992) 0.86
Time dependence of hematoporphyrin distribution in selected tissues of normal rats and in ascites hepatoma. Tumori (1979) 0.86
Stereotactic radiosurgery utilizing a linear accelerator. Appl Neurophysiol (1985) 0.85
Combined radiosurgery and external radiotherapy of intracranial germinomas. Surg Neurol (1990) 0.84
PC-10 antibody to proliferating cell nuclear antigen (PCNA) is not related to prognosis in human breast carcinoma. Growth Regul (1992) 0.84
Simultaneous cis-platinum and radiotherapy in inoperable or locally advanced squamous cell carcinoma of the head and neck. Oncology (1991) 0.82
A multiparametric study on the prognostic value of epidermal growth factor receptor in operable breast carcinoma. Breast Cancer Res Treat (1994) 0.82
Experience of vaccination against invasive bacterial diseases in Veneto region (north east Italy). J Prev Med Hyg (2012) 0.81
Correlation of growth fraction by Ki-67 immunohistochemistry with histologic factors and hormone receptors in operable breast carcinoma. Breast Cancer Res Treat (1989) 0.81
Conservative surgery and irradiation (QUART) in the treatment of 243 stage I-II breast cancer patients. Anticancer Res (1992) 0.80
Gynecologic cancer recurrences and photodynamic therapy: our experience. J Clin Laser Med Surg (1995) 0.80
Ultrarapid high-dose course of prophylactic cranial irradiation in small-cell lung cancer: evaluation of late neurologic morbidity in 16 long-term survivors. Am J Clin Oncol (1998) 0.79
Linear accelerator radiosurgery of three-dimensional irregular targets. Stereotact Funct Neurosurg (1990) 0.79
Linear accelerator radiosurgery of arteriovenous malformations. Appl Neurophysiol (1987) 0.78
Radiosurgery using a 4MV linear accelerator. Technique and radiobiologic implications. Acta Radiol Suppl (1986) 0.77
Osteogenic osteosarcoma of the calvaria following radiotherapy for cerebellar astrocytoma: report of a case in childhood. Tumori (1985) 0.77
Photodynamic therapy in gynaecological neoplastic diseases. J Photochem Photobiol B (1996) 0.77
Relationship of the epidermal growth factor-receptor to the growth fraction (Ki-67 antibody) and the flow cytometric S-phase as cell kinetics parameters, in human mammary carcinomas. Anticancer Res (1992) 0.77
Recurring gynaecologic cancer treated with photodynamic therapy. Photochem Photobiol (1987) 0.76
[Meningeal prophylaxis with radiocolloids in childhood leukemia and non-Hodgkin's lymphoma]. Radiol Med (1986) 0.76
Osteosarcoma of the facial bones. Ann Oncol (1992) 0.75
[Laser-photo-radiotherapy in the treatment malignant tumors]. Radiol Med (1987) 0.75
Treatment of 49 unrandomized patients with advanced Hodgkin's disease. Tumori (1983) 0.75
Treatment of locally advanced squamous-cell carcinoma of the head and neck with concurrent radiochemotherapy - randomized comparison of Cisplatin versus Carboplatin. Int J Oncol (1993) 0.75
[Stereotaxic irradiation with a linear accelerator]. Radiol Med (1984) 0.75
[Medical thermography: a new contribution to the early diagnosis of breast cancer?]. Acta Chir Ital (1970) 0.75
[Photodynamic therapy in gastroenterology]. G Clin Med (1990) 0.75
Surgical and adjuvant radiation therapy of resectable retroperitoneal soft tissue sarcomas in adults. Tumori (1992) 0.75
Factors governing the mechanism and efficiency of porphyrin-sensitized photooxidations in homogeneous solutions and organized media. Adv Exp Med Biol (1983) 0.75
[Comparative study of the changes in the elimination of 17-ketosteroids in male rats after surgical and radiation-induced castration and histologic study of the testes irradiated with scalar doses]. Quad Radiol (1970) 0.75
[Advanced stages of rectosigmoid cancer. The role of postoperative radiotherapy]. Radiol Med (1989) 0.75
[Histochemical behavior of some enzymes of mucosa of the small intestine in irradiated animals]. Minerva Radiol (1966) 0.75
Locally advanced breast-carcinoma - results of a multimodal therapy including alternating neoadjuvant chemotherapy, surgery and radiotherapy. Int J Oncol (1992) 0.75
Development of a second generation stereotactic apparatus for linear accelerator radiosurgery. Acta Neurochir Suppl (Wien) (1991) 0.75
Pathobiological characteristics of the 1st primary and risk of metachronous contralateral invasive breast-carcinoma - clinical implications. Int J Oncol (1993) 0.75
[Cyclophosphamide and total lymph node irradiation as conditioning for bone marrow transplant in severe aplastic anemia]. Radiol Med (1987) 0.75
A retrospective analysis concerning physical aspects and clinical dosimetry in radiosurgery. J Neurosurg Sci (1989) 0.75
[Analysis of recurrences following conservative treatment of breast carcinoma]. Radiol Med (1995) 0.75
[Duplication and "pseudo-duplication" of the gallbladder]. Quad Radiol (1968) 0.75
[Current therapeutic trends in Hodgkin's disease (case reports)]. Friuli Med (1970) 0.75
Radioiodinated fibrinogen in the evaluation of patients with osteosarcoma. Eur J Cancer (1980) 0.75
Synchronous radiotherapy and chemotherapy with cisplatin in the management of locally advanced or recurrent head and neck cancer. Am J Clin Oncol (1992) 0.75
Ovarian function after pelvic lymph node irradiation in patients with Hodgkin's disease submitted to oophoropexy during laparotomy. Eur J Gynaecol Oncol (1980) 0.75
Peritumoral lymphatic vessel invasion compared with DNA ploidy, proliferative activity, and other pathologic features as prognostic indicators in operable breast cancer. Breast Cancer Res Treat (1992) 0.75
Multivariate-analysis of prognostic factors in 232 patients with clinical stage-I endometrial adenocarcinoma using the new figo surgical staging system. Int J Oncol (1992) 0.75
Stereotactic radiosurgery of intracranial tumors in childhood. J Neurosurg Sci (1986) 0.75
[Neoplasms of the gallbladder and the extrahepatic bile ducts: radio-chemotherapeutic combined treatment. Results in 18 treated cases]. Radiol Med (1991) 0.75
[Electron microscopy of tissues after treatment with laser radiations]. Friuli Med (1970) 0.75
[Histological and histochemical behavior of mature bone exposed to ionizing radiations]. Quad Radiol (1969) 0.75
Dosimetry in interstitial curietherapy: comments on the Manchester and Paris systems as an introduction to a new system of dosimetry. Rays (1987) 0.75
[Association of ionizing radiations and ultrasonics in the therapy of chilblains]. Minerva Radiol (1968) 0.75
[Endocurietherapy in cancer of the bladder. A new technique by implant of 192iridium with Cyponil tubes (author's transl)]. J Radiol (1979) 0.75
[Behavior of acridine-orange (A-O) fluorochrome in cellular elements exposed to ionizing radiations. I. Research in vitro]. Minerva Med (1970) 0.75
[Evaluation of late lesions following therapy with fast electrons]. Strahlentherapie (1968) 0.75
[The use of iridium192 in a cyponil tube as a modification of the "silk thread" technique in direct local radiotherapy of the skin (author's transl)]. J Radiol Electrol Med Nucl (1977) 0.75
[Scintiscanning with radiostrontium in osseous metastases]. Quad Radiol (1969) 0.75
[Characteristics of P 32 "Bremsstrahlung" in material of uniform density: experimental dosimetry]. Acta Isot (Padova) (1967) 0.75
Radiotherapeutic treatment for breast cancer choroidal metastases. Tumori (1990) 0.75
Effect of hematoporphyrin and red light on AH-130 solid tumors in rats. Acta Radiol Oncol (1983) 0.75
[Endoscopic laser therapy of inoperable carcinoma of the esophagus]. G Clin Med (1988) 0.75
Progesterone receptor determined by immunocytochemical and biochemical methods in human breast cancer. J Cancer Res Clin Oncol (1992) 0.75
[High energy radiography (4 MV). Practical results]. J Radiol Electrol Med Nucl (1975) 0.75
[Small size breast cancer conservative surgical therapy and subsequent radiotherapy]. Chir Ital (1988) 0.75
Linear accelerator radiosurgery of cerebral arteriovenous malformations: current status. Acta Neurochir Suppl (1994) 0.75
[Methodologic proposals on the subject of pancreatic scintigraphy]. Quad Radiol (1969) 0.75
[Stereotaxic radiosurgery using photon beam radiation from a linear accelerator]. Med Radiol (Mosk) (1989) 0.75
[Biopsy and stereotaxic radiotherapy of cerebral gliomas]. Minerva Med (1984) 0.75
Sensitivity to radiations of Mg2+ and (Ca2+ + Mg2+) ATPase activities associated with erythrocyte membrane fragments. Acta Radiol Oncol (1982) 0.75
[Clinical comparison of the kinetics of 99mTc pyrophosphate and 99mTc methylene diphosphonate (author's transl)]. Radiol Med (1979) 0.75
[Dosimetry of the bladder and the rectum: comparison between the measured and calculated dose (author's transl)]. Radiol Med (1981) 0.75
From radiotherapy to stereotactic radiosurgery: physical and dosimetrical considerations. Radiother Oncol (1993) 0.75
[Teleradiotherapy in the treatment of thyroid neoplasms]. Chir Ital (1994) 0.75
Analysis of dosimetric measurements in linac radiosurgery calibration. Radiother Oncol (1993) 0.75
[Influence of Fleming's lysozyme on leukopenia due to radiotherapy. Case contribution]. Quad Radiol (1966) 0.75
Treatment of early stage Hodgkin's disease with radiation therapy plus short-cycle (3 MOPP) adjuvant chemotherapy. Tumori (1983) 0.75
Phase I study of escalating dose mitoxantrone in combination with alpha-2-interferon in patients with advanced solid tumors. Invest New Drugs (1991) 0.75
Photoradiation therapy for cutaneous and subcutaneous malignant tumors using hematoporphyrin. Prog Clin Biol Res (1984) 0.75
[Some pituitary-adrenal histological aspects in dogs in deep hypothermia]. Acta Anaesthesiol (1965) 0.75
[Increasing childhood immunization coverage by establishing structured relationships with pediatricians and family practitioners]. Ann Ig (2012) 0.75
[The effect of "Laser radiation" on living cells stained with acridine orange]. Minerva Radiol (1968) 0.75
[Use of lasers in gastroenterology]. G Clin Med (1990) 0.75
[Physical and radiobiological aspects of the penumbra in radiotherapy. I. Effects of the penumbra in cesium teletherapy]. Minerva Radiol (1966) 0.75
Serum selenium levels in malignant lymphoproliferative diseases. Scand J Haematol (1980) 0.75